BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vasogen Inc. 

2155 Dunwin Drive, Suite 10

Toronto  Ontario  L5L4M1  Canada
Phone: 905-569-2265 Fax: 905-569-9231


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
IntelliPharmaCeutics and Vasogen (VSGN) Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical Company 10/22/2009 10:58:01 AM    More...
Vasogen (VSGN) and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger 10/20/2009 10:42:15 AM    More...
Vasogen (VSGN) Announces Third Quarter 2009 Results 10/15/2009 9:16:23 AM    More...
Vasogen (VSGN) Receives NASDAQ Notification Related to Minimum Bid Price 8/17/2009 8:37:16 AM    More...
Vasogen (VSGN) and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company; Vasogen Also Raises $7.5 Million 8/17/2009 6:35:29 AM    More...
Vasogen (VSGN) Announces Second Quarter 2009 Results 7/15/2009 8:44:24 AM    More...
Vasogen (VSGN) Appoints Dr. Eldon Smith Chairman 4/27/2009 12:04:56 PM    More...
Vasogen (VSGN) Announces First Quarter 2009 Results 4/14/2009 9:37:39 AM    More...
Vasogen (VSGN) Announces Sale of Patent Application and Provides Corporate Update 2/3/2009 11:09:11 AM    More...
Vasogen (VSGN) Complies with NASDAQ Marketplace Rule 4350(c)(1) 1/21/2009 8:24:12 AM    More...
12345678910...